Medeon Biodesign (ROCO:6499) E10: NT$-1.86 (As of Dec. 2025)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

ROCO:6499 Medeon Biodesign Inc ROCO:6499
68 GF Score
Price NT$69.80
GF Value NT$107.08
Valuation Significantly Undervalued
! 1 Warning Sign
View Full Analysis

What is Medeon Biodesign E10?

Medeon Biodesign ROCO:6499 -1.69% 68 E10 is NT$-1.86 as of Dec. 2025. GuruFocus rates ROCO:6499 with a GF Score™ of 68/100 and a GF Value™ of NT$107.08 (Significantly Undervalued). The stock has 1 warning sign investors should review.

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years.

Medeon Biodesign's adjusted earnings per share data for the three months ended in Dec. 2025 was NT$-1.536. Add all the adjusted EPS for the past 10 years together and divide 10 will get our e10, which is NT$-1.86 for the trailing ten years ended in Dec. 2025.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the E10 growth rate using E10 data.

As of today (2026-07-13), Medeon Biodesign's current stock price is NT$69.80. Medeon Biodesign's E10 for the quarter that ended in Dec. 2025 was NT$-1.86. Medeon Biodesign's Shiller PE Ratio of today is .


Medeon Biodesign  (ROCO:6499) E10 Explanation

If a company grows much fast than inflation, E10 may underestimate the company's earnings power. Shiller PE Ratio can seem to be too high even the actual P/E is low.

For the Shiller P/E, the earnings of the past 10 years are inflation-adjusted and averaged. The result is used for P/E calculation. Since it looks at the average over the last 10 years, the Shiller P/E is also called PE10.

The Shiller P/E was first used by professor Robert Shiller to measure the valuation of the overall market. The same calculation is applied here to individual companies.


Be Aware

Shiller PE Ratio works better for cyclical companies. It gives you a better idea on the company's real earnings power.


Medeon Biodesign E10 Related Terms


Medeon Biodesign E10 Historical Data

* Premium members only.

The historical data trend for Medeon Biodesign's E10 can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Medeon Biodesign E10 Chart

Medeon Biodesign Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
E10
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 -0.57 -1.40 -1.86

Medeon Biodesign Quarterly Data
Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25
E10 Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1.40 -1.56 -1.70 -1.83 -1.86

ROCO:6499 vs ISRG, BDX, MDLN: E10 Comparison

For the Medical Instruments & Supplies subindustry, Medeon Biodesign's Shiller PE Ratio, along with its competitors' market caps and Shiller PE Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Medeon Biodesign Shiller PE Ratio vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Medeon Biodesign's Shiller PE Ratio distribution charts can be found below:

* The bar in red indicates where Medeon Biodesign's Shiller PE Ratio falls into.


ROCO:6499
68GF Score
Medeon Biodesign Inc ROCO:6499
E10 is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Medeon Biodesign E10 Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller P/E calculation. When we calculate the today's Shiller P/E ratio of a stock, we use today's price divided by E10.

What is E10? How do we calculate E10?

E10 is the average of the inflation adjusted earnings of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the E10 of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the earnings from 2001 through 2010.

We adjusted the earnings of 2001 earnings data with the total inflation from 2001 through 2010 to the equivalent earnings in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart earned $1 a share in 2001, then the 2001's equivalent earnings in 2010 is $1.4 a share. If Wal-Mart earns $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 earnings in 2010 is $1.35. So on and so forth, you get the equivalent earnings of past 10 years. Then you add them together and divided the sum by 10 to get E10.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Medeon Biodesign's adjusted earnings per share data for the three months ended in Dec. 2025 was:

Adj_EPS= Earnings per Share (Diluted) /CPI of Dec. 2025 (Change)*Current CPI (Dec. 2025)
=-1.536/324.0540*324.0540
=-1.536

Current CPI (Dec. 2025) = 324.0540.

Medeon Biodesign Quarterly Data

per share eps CPI Adj_EPS
201603 -0.718 238.132 -0.977
201606 -0.660 241.018 -0.887
201609 -0.718 241.428 -0.964
201612 -0.906 241.432 -1.216
201703 -0.699 243.801 -0.929
201706 -0.757 244.955 -1.001
201709 -0.692 246.819 -0.909
201712 -0.977 246.524 -1.284
201803 4.612 249.554 5.989
201806 -0.286 251.989 -0.368
201809 -0.607 252.439 -0.779
201812 -0.536 251.233 -0.691
201903 -0.586 254.202 -0.747
201906 -0.600 256.143 -0.759
201909 -0.750 256.759 -0.947
201912 -0.893 256.974 -1.126
202003 -0.572 258.115 -0.718
202006 -0.672 257.797 -0.845
202009 -0.692 260.280 -0.862
202012 -0.157 260.474 -0.195
202103 -0.786 264.877 -0.962
202106 26.312 271.696 31.383
202109 -1.933 274.310 -2.284
202112 -1.245 278.802 -1.447
202203 0.717 287.504 0.808
202206 -2.065 296.311 -2.258
202209 -1.347 296.808 -1.471
202212 -1.980 296.797 -2.162
202303 -1.872 301.836 -2.010
202306 -6.803 305.109 -7.225
202309 -2.089 307.789 -2.199
202312 -2.198 306.746 -2.322
202403 -2.149 312.332 -2.230
202406 -2.287 314.175 -2.359
202409 -1.980 315.301 -2.035
202412 -2.323 315.605 -2.385
202503 -1.911 319.799 -1.936
202506 -1.911 322.561 -1.920
202509 -1.881 324.800 -1.877
202512 -1.536 324.054 -1.536

Add all the adjusted EPS together and divide 10 will get our e10.

Frequently Asked Questions Learn more about E10 →
What does a E10 of NT$-1.86 mean?
Medeon Biodesign (ROCO:6499) has a E10 of NT$-1.86 as of Dec. 2025. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medeon Biodesign and its competitors.
Is Medeon Biodesign's E10 too high?
Medeon Biodesign's current E10 is NT$-1.86. Overall, Medeon Biodesign has a GF Score™ of 68/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Medeon Biodesign's E10 compare to ISRG and BDX?
Medeon Biodesign's E10 of NT$-1.86 can be compared against companies in the Medical Devices & Instruments industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good E10 for a Medical Devices & Instruments company?
A good E10 depends on the Medical Devices & Instruments industry context. However, E10 should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high E10 mean?
A high E10 can signal that a stock is expensive relative to its fundamentals. E10 represents the company's inflation-adjusted earnings per share over a 10-year period. View historical data on Medeon Biodesign and its competitors. Medeon Biodesign's current E10 is NT$-1.86. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Medeon Biodesign stock overvalued right now?
Based on GuruFocus' analysis, Medeon Biodesign (ROCO:6499) is currently considered Significantly Undervalued. The stock's GF Value™ is NT$107.08, compared to a current price of NT$69.80 — trading 34.8% below its estimated fair value. The current E10 is NT$-1.86. Medeon Biodesign's overall GF Score™ is 68/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is E10 calculated?
E10 is calculated from a company's financial statements. For Medeon Biodesign (ROCO:6499), the current E10 is NT$-1.86 as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Medeon Biodesign (ROCO:6499) Overvalued in 2026?

Based on GuruFocus' analysis, Medeon Biodesign stock appears to be undervalued. The current stock price of NT$69.80 is trading 34.8% below its estimated GF Value™ of NT$107.08. GuruFocus considers Medeon Biodesign to be Significantly Undervalued.

Key valuation signals for ROCO:6499:

  • E10: NT$-1.86
  • GF Value™: NT$107.08 vs. price of NT$69.80 (34.8% below fair value)
  • GF Score™: 68/100 with 1 warning sign

No single metric tells the full story. See the ROCO:6499 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Medeon Biodesign Business Description

Address No. 116, HouGang Street, 7th Floor, Shilin District, Taipei, TWN, 11170
Medeon Biodesign Inc develops medical device products. The main services of the Group are the research and development of medical devices, manufacturing, and sale of injection molding and components of medical devices. The company provides products in the fields of cardiovascular and laparoscopic. Its business includes Medical Device Development Department and Medical Device Components Manufacturing and Sales Department. The majority of the company revenue comes from Medical Device Components Manufacturing and Sales Department segment. The company revenue is mainly derived from the USA.
68GF Score

Get the complete analysis for ROCO:6499

E10 is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

NT$69.80
Price
NT$107.08
GF Value